Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Product Developments And Launches By Market Players Promote Market Growth
2.5.2. Prevalence Of Diabetes And Cancer

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Infertility Incidences
3.1.2. Assisted Reproductive Technology Adoption
3.1.3. Technological Advancements
3.2. Key Restraints
3.2.1. High Treatment Costs

4. Key Analytics
4.1. Key Market Trends
4.2. Porter’S Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.4. Market Maturity Analysis
4.5. Market Concentration Analysis

5. Market By Test Type
5.1. Dna Fragmentation Technique
5.2. Oxidative Stress Analysis
5.3. Microscopic Examination
5.4. Sperm Agglutination
5.5. Computer-Assisted Semen Analysis
5.6. Sperm Penetration Assay
5.7. Other Test Types

6. Market By Treatment
6.1. Assisted Reproductive Technology And Surgery
6.2. Medications

7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. North America Male Infertility Market Drivers
7.1.3. North America Male Infertility Market Challenges
7.1.4. Key Players In North America Male Infertility Market
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.1.1. United States Male Infertility Market Size & Opportunities
7.1.5.2. Canada
7.1.5.2.1. Canada Male Infertility Market Size & Opportunities

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions
8.2. Company Profiles
8.2.1. Advacare Pharma Usa
8.2.1.1. Company Overview
8.2.1.2. Products / Services List
8.2.2. Andrology Solutions
8.2.2.1. Company Overview
8.2.2.2. Products / Services List
8.2.3. Aytu Biopharma
8.2.3.1. Company Overview
8.2.3.2. Products / Services List
8.2.3.3. Strengths & Challenges
8.2.4. Bayer Group
8.2.4.1. Company Overview
8.2.4.2. Products / Services List
8.2.4.3. Strengths & Challenges
8.2.5. Caerus Biotech
8.2.5.1. Company Overview
8.2.5.2. Products / Services List
8.2.6. Cinnagen Co
8.2.6.1. Company Overview
8.2.6.2. Products / Services List
8.2.6.3. Strengths & Challenges
8.2.7. Emd Serono Inc (Merck Serono)
8.2.7.1. Company Overview
8.2.7.2. Products / Services List
8.2.7.3. Strengths & Challenges
8.2.8. Endo International Plc
8.2.8.1. Company Overview
8.2.8.2. Products / Services List
8.2.8.3. Strengths & Challenges
8.2.9. Halotech Dna
8.2.9.1. Company Overview
8.2.9.2. Products / Services List
8.2.10. Laboratory Corporation Of America Holdings
8.2.10.1. Company Overview
8.2.10.2. Products / Services List
8.2.10.3. Strengths & Challenges
8.2.11. Sanofi
8.2.11.1. Company Overview
8.2.11.2. Products / Services List
8.2.11.3. Strengths & Challenges
8.2.12. Scsa Diagnostics
8.2.12.1. Company Overview
8.2.12.2. Products / Services List
8.2.13. Theramex
8.2.13.1. Company Overview
8.2.13.2. Products / Services List
8.2.14. Vitrolife
8.2.14.1. Company Overview
8.2.14.2. Products / Services List
8.2.14.3. Strengths & Challenges
8.2.15. Zydus Lifesciences Ltd (Cadila Healthcare Ltd)
8.2.15.1. Company Overview
8.2.15.2. Products / Services List
8.2.15.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Porter’S Five Forces Analysis
Figure 2: Growth Prospect Mapping
Figure 3: Market Maturity Analysis
Figure 4: Market Concentration Analysis
Figure 5: North America Male Infertility Market, Growth Potential, By Test Type, In 2022
Figure 6: North America Male Infertility Market, By Dna Fragmentation Technique, 2023-2032 (In $ Million)
Figure 7: North America Male Infertility Market, By Dna Fragmentation Technique, 2023-2032 (In $ Million)
Figure 8: North America Male Infertility Market, By Oxidative Stress Analysis, 2023-2032 (In $ Million)
Figure 9: North America Male Infertility Market, By Microscopic Examination, 2023-2032 (In $ Million)
Figure 10: North America Male Infertility Market, By Sperm Agglutination, 2023-2032 (In $ Million)
Figure 11: North America Male Infertility Market, By Computer-Assisted Semen Analysis, 2023-2032 (In $ Million)
Figure 12: North America Male Infertility Market, By Sperm Penetration Assay, 2023-2032 (In $ Million)
Figure 13: North America Male Infertility Market, By Other Test Types, 2023-2032 (In $ Million)
Figure 14: North America Treatment Market, Growth Potential, By Treatment, In 2022
Figure 15: North America Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2032 (In $ Million)
Figure 16: North America Male Infertility Market, By Medications, 2023-2032 (In $ Million)
Figure 17: North America Male Infertility Market, Country Outlook, 2022 & 2032 (In %)
Figure 18: United States Male Infertility Market, 2023-2032 (In $ Million)
Figure 19: Canada Male Infertility Market, 2023-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MALE INFERTILITY
TABLE 2: NORTH AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: KEY PLAYERS OPERATING IN NORTH AMERICA MALE INFERTILITY MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS